Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 3/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | F7 | P08709 | 2/20 | 0.45 |
| ▸ | F3 | P13726 | 2/20 | 0.45 |
| ▸ | FAAH | O00519 | 4/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | TERT | O14746 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3138791 | 1.00 | PPARA (0.48) | PPARAEPHX2F7F3FAAH | |
| SCHEMBL1310713 | 0.98 | PPARA (0.47) | PPARAEPHX2F7F3FAAH | |
| SCHEMBL3135640 | 0.93 | EPHX2 (0.53) | PPARAEPHX2F7F3FAAH | |
| SCHEMBL17361017 | 0.93 | EPHX2 (0.53) | PPARAEPHX2F7F3FAAH | |
| SCHEMBL11377546 | 0.91 | EPHX2 (0.56) | PPARAEPHX2F7F3FAAH | |
| SCHEMBL11504832 | 0.91 | EPHX2 (0.56) | PPARAEPHX2F7F3FAAH | |
| SCHEMBL3134105 | 0.91 | EPHX2 (0.56) | PPARAEPHX2F7F3FAAH | |
| SCHEMBL11504115 | 0.91 | EPHX2 (0.56) | PPARAEPHX2F7F3FAAH | |
| SCHEMBL11504005 | 0.91 | EPHX2 (0.56) | PPARAEPHX2F7F3FAAH | |
| SCHEMBL11505334 | 0.91 | EPHX2 (0.56) | PPARAEPHX2F7F3FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2740781-B1 | FOAMING COMPOSITION WITH WETTABILITY MODIFYING AND CORROSION INHIBITORY PROPERTIES FOR HIGH TEMPERATURE AND ULTRA-HIGH SALINITY | INST MEXICANO DEL PETRÓLEO (MX) | 2015-12-30 | — | — | EP | claimed |
| EP-2474527-B1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEM IND LTD (JP) | 2017-01-25 | — | — | EP | disclosed |
| US-8722588-B2 | Foaming composition for high temperature and salinity | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2014-05-13 | — | — | US | disclosed |
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20110275546-A1 | FOAMING COMPOSITION FOR HIGH TEMPERATURE AND SALINITY | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2011-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | PPARA 3793/4885EPHX2 4160/4885F7 305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.